London Patients to Benefit Expanded Health Partnership

The Royal Marsden NHS Foundation Trust and the Royal Brompton & Harefield NHS Foundation Trust have joined the Imperial College Academic Health Science Centre (AHSC). This brings together 21,500 clinicians and other NHS staff, researchers and academics to drive innovation and improved care for the direct benefit of over 1.1 million patients each year in North West London.

With existing members Imperial College London and Imperial College Healthcare Trust, the extended collaboration will further align the international reputation for research, education and clinical services of the four organisations with particular strengths in research and care for cancer and heart and lung diseases.

The AHSC will build on existing collaborative projects between the partners, including the West London Genomic Medicine Centre, which is playing a key role in the successful delivery of the 100,000 Genomes Project; the RM Partners Cancer Vanguard, which is developing new models of cancer care; and joint lung cancer research projects.

Professor Alice Gast, President, Imperial College London, said: “We warmly welcome our new partners in Imperial College Academic Health Science Centre. Each institution in the Imperial College AHSC is world-leading in its own right and we can achieve even more by working together and combining our expertise and our strengths. This expansion represents an important and exciting milestone in our mission to enhance and transform healthcare in the UK and across the world.”